GEMA Share Price Performance
Recent GEMA News & Updates
No updates
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company Key Details
Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 85.13
- Gross Margin
- 85.59%
- Net Profit Margin
- 48.66%
- Debt/Equity Ratio
- 12.9%
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company Competitors
About GEMA
- Founded
- 2003
- Employees
- n/a
- CEO
- WebsiteView website
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a licensed bank for personal storage of cord blood stem cells and tissue of the umbilical cord in Russia and the CIS countries. The company was founded in 2003 and is based in Moscow, Russia. International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company is a subsidiary of Human Stem Cells Institute PJSC.
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading